This Act prohibits entities from owning both a pharmacy and an insurance company or Pharmacy Benefit Manager (PBM) to eliminate conflicts of interest and restore competition in the prescription drug market.
Elizabeth Warren
Senator
MA
The Patients Before Monopolies Act aims to restore competition in the prescription drug market by structurally separating vertically integrated health conglomerates. This is achieved by making it illegal for any entity to own both a pharmacy and either an insurer or a Pharmacy Benefit Manager (PBM). The bill mandates divestiture of any conflicting ownership within one year and grants the FTC and DOJ strong enforcement and civil penalty authority to ensure compliance.
PBM Act Targets Healthcare Giants with Mandatory Pharmacy Divestment to Lower Drug Costs
The Patients Before Monopolies Act (PBM Act) aims to break up the massive healthcare conglomerates that currently control everything from your insurance plan to the pharmacy where you pick up your meds. By prohibiting any single company from owning a pharmacy while also operating as an insurance provider or a Pharmacy Benefit Manager (PBM), the bill seeks to end the 'self-preferencing' that often leads to higher prices for patients and the closure of local independent pharmacies. If passed, companies in violation of this rule would have exactly one year to sell off their pharmacy businesses (Sec. 3).
Breaking Up the Big Box Pharmacy
Currently, the six largest PBMs handle over 90% of U.S. prescriptions, and most are owned by the same companies that run your insurance and their own mail-order pharmacies. This bill forces a 'structural separation' of these businesses. For a family trying to manage a chronic condition, this could mean more choices in where they get their prescriptions filled without being forced into a specific mail-order service. For the local pharmacist on Main Street, it means they might finally stop getting squeezed by 'unfavorable contracts' from the very PBMs that are also their direct competitors (Sec. 2).
The One-Year Countdown
To ensure these changes actually happen, the bill sets a strict timeline. Within 30 days of the law taking effect, the FTC and DOJ must issue a roadmap for companies to follow. If a giant healthcare corporation drags its feet on selling its pharmacy arm, the government can seize 10% of their monthly profits and hold them in an escrow account until they comply (Sec. 3). If they still haven't sold by the one-year mark, a court-appointed trustee takes over and sells the pharmacy for them. This is a high-stakes move designed to prevent corporations from stalling in court for years.
Power to the People (and the Courts)
This legislation doesn't just rely on government bureaucrats; it gives regular people the right to sue. If you’ve been financially harmed by these monopolies, you can bring a private lawsuit and potentially win 'treble damages'—that’s three times the actual money you lost—plus your attorney fees (Sec. 3). Additionally, any money the government claw back from these companies through 'disgorgement' (giving up illegal profits) is funneled into a special fund used to help overcharged consumers and support healthcare needs in the communities that were hit hardest by these practices.